Nexalin Technology NXL
NASDAQ NXL
$0.34 +0.01 (+1.89%)
At close: Aug 20, 2026 · 10:26 AM UTC

Nexalin Technology (NXL) Net Income towards Common Stockholders (2021 - 2026)

Nexalin Technology (NXL) posted quarterly Net Income towards Common Stockholders of -$2.1 million for Q1 2026, down 5.51% year-over-year from -$2.2 million in Q1 2025, and up 11.77% quarter-over-quarter from -$2.4 million in Q4 2025.

Nexalin Technology (NXL) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends

Nexalin Technology's Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at -$2.1 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders fell 5.51% year-over-year to -$2.1 million; the TTM figure through Mar 2026 stood at -$8.3 million (up 2.55% YoY), while the FY2025 annual figure was -$6.5 million, up 14.62% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$2.1 million, up from -$2.4 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was -$303646.0 in Q3 2022, with the low at -$2.8 million in Q4 2024.
  • The 5-year median for Net Income towards Common Stockholders is -$1.3 million (2024), against an average of -$1.4 million.
  • The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders soared 83.34% in 2022, then sank 656.54% in 2023.
  • Nexalin Technology's Net Income towards Common Stockholders stood at -$758617.0 in 2022, then slipped by 2.91% to -$780669.0 in 2023, then tumbled by 262.33% to -$2.8 million in 2024, then gained by 15.98% to -$2.4 million in 2025, then advanced by 11.77% to -$2.1 million in 2026.
  • Business Quant data shows NXL's Net Income towards Common Stockholders at -$2.1 million in Q1 2026, -$2.4 million in Q4 2025, and -$2.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.99 Bn 194.39 Bn 7.27 Bn 928.00 Mn
2 Stryker 129.76 Bn 126.29 Bn 4.50 Bn 1.28 Bn
3 Medtronic 120.27 Bn 111.05 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 73.98 Bn 73.44 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 52.67 Bn 48.42 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.63 Bn 32.68 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 34.11 Bn 32.00 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.50 Bn 23.18 Bn 4.55 Bn 621.86 Mn
9 Steris 23.22 Bn 22.74 Bn 684.20 Mn 201.00 Mn
10 Nexalin Technology 7.11 Mn 6.11 Mn 8,897.00 -2.24 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.24 Mn
Mar 31, 2026 -2.10 Mn
Dec 31, 2025 -2.38 Mn
Sep 30, 2025 -2.28 Mn
Jun 30, 2025 -1.58 Mn
Mar 31, 2025 -1.99 Mn
Dec 31, 2024 -2.83 Mn
Sep 30, 2024 -2.45 Mn
Jun 30, 2024 -1.28 Mn
Mar 31, 2024 -1.05 Mn
Dec 31, 2023 -780,669.00
Sep 30, 2023 -2.30 Mn
Jun 30, 2023 -822,437.00
Mar 31, 2023 -748,414.00
Dec 31, 2022 -758,617.00
Sep 30, 2022 -303,646.00
Jun 30, 2022 -450,103.00
Mar 31, 2022 -393,249.00
Dec 31, 2021 -595,928.00
Sep 30, 2021 -1.82 Mn